Anti-Glaucoma Eye Drops Franchise in Ahmedabad

Timolol + Brimonidine Eye Drops Supplier in Mumbai

Ophthalmic Glaucoma Care Distributor in Delhi

Eye Pressure Control Pharma Franchise in Bangalore

Timolol Brimonidine Eye Drops Stockist in Hyderabad
Anti-Glaucoma Combination Ophthalmic Drop Manufacturer & Exporter in Chandigarh

Home/Products /timolol-5mg-ml-brimonidine-1-5mg-ml-eye-drop

Travopine B 1.5 Eye Drop

Composition : Timolol (5mg/ml) + Brimonidine (1.5mg/ml) Eye Drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 10ml

Price : ₹0/-

Please Contact For Best Price

Travopine B 1.5 Eye Drop contains Timolol 5mg/ml + Brimonidine 1.5mg/ml, a dual-action anti-glaucoma ophthalmic formulation used for effective reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension. Its well-balanced combination ensures reliable and sustained pressure control.

The eye drop works by reducing aqueous humor production through Timolol and decreasing aqueous formation while enhancing outflow via Brimonidine, providing comprehensive intraocular pressure management and optic nerve protection.

From a franchise perspective, Travopine B 1.5 Eye Drop is a high-demand combination therapy, commonly prescribed in eye hospitals, ophthalmology clinics, and glaucoma care centers, ensuring steady prescriptions and repeat business.

Adding Travopine B 1.5 Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma combination segment, offering long-term market stability, strong prescriber confidence, and enhanced portfolio value for PCD pharma franchise partners.


Read More

About the Product

Travopine B 1.5 Eye Drop contains Timolol 5mg/ml + Brimonidine 1.5mg/ml, a dual-action anti-glaucoma ophthalmic formulation used for effective reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension. Its well-balanced combination ensures reliable and sustained pressure control.

The eye drop works by reducing aqueous humor production through Timolol and decreasing aqueous formation while enhancing outflow via Brimonidine, providing comprehensive intraocular pressure management and optic nerve protection.

From a franchise perspective, Travopine B 1.5 Eye Drop is a high-demand combination therapy, commonly prescribed in eye hospitals, ophthalmology clinics, and glaucoma care centers, ensuring steady prescriptions and repeat business.

Adding Travopine B 1.5 Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma combination segment, offering long-term market stability, strong prescriber confidence, and enhanced portfolio value for PCD pharma franchise partners.


Common side effects may include burning or stinging sensation, eye redness, dryness, itching, or blurred vision. Systemic effects such as fatigue, dizziness, dry mouth, slow heart rate, or drowsiness may occur rarely, especially in susceptible individuals.

Travopine B 1.5 Eye Drop is indicated for the management of open-angle glaucoma and ocular hypertension in patients who require combination therapy for adequate intraocular pressure reduction. It is used under the supervision of an ophthalmologist.

Use Travopine B 1.5 Eye Drop strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Use with caution in patients with asthma, COPD, cardiovascular disease, or those taking antihypertensive medications. Seek medical advice immediately if breathing difficulty, severe eye irritation, or vision changes occur.

Store in a cool, dry place below 25 °C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use after the expiry date.

Get in Touch